# EDGAR Filing Document

**Accession Number:** 0001756262
**File Stem:** 0001193125-26-150360
**Filing Date:** 2026-4
**Character Count:** 4992
**Document Hash:** 278810d563de786b7b1256cfc6fcf122
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193125-26-150360.hdr.sgml**: 20260410

**ACCESSION NUMBER**: 0001193125-26-150360

**CONFORMED SUBMISSION TYPE**: DEFA14A

**PUBLIC DOCUMENT COUNT**: 3

**FILED AS OF DATE**: 20260410

**DATE AS OF CHANGE**: 20260410

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** TransMedics Group, Inc.
- **CENTRAL INDEX KEY:** 0001756262
- **STANDARD INDUSTRIAL CLASSIFICATION:** ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 000000000
- **STATE OF INCORPORATION:** MA
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** DEFA14A
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-38891
- **FILM NUMBER:** 26853188

**BUSINESS ADDRESS:**
- **STREET 1:** 200 MINUTEMAN ROAD
- **CITY:** ANDOVER
- **STATE:** MA
- **ZIP:** 01810
- **BUSINESS PHONE:** 9785520900

**MAIL ADDRESS:**
- **STREET 1:** 200 MINUTEMAN ROAD
- **CITY:** ANDOVER
- **STATE:** MA
- **ZIP:** 01810

**UNITED STATES** 

**SECURITIES AND EXCHANGE COMMISSION** 

**Washington, D.C. 20549** 

**SCHEDULE 14A** 

**Proxy Statement Pursuant to Section 14(a) of the** 

**Securities Exchange Act of 1934** 

Filed by the Registrant ☒

Filed by a Party other than the Registrant ☐

Check the appropriate box:

☐ Preliminary Proxy Statement

☐ **Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))** 

☐ Definitive Proxy Statement

☒ Definitive Additional Materials

☐ Soliciting Material under §240.14a-12

**TRANSMEDICS GROUP, INC.** 

**(Name of Registrant as Specified in Its Charter)** 

**(Name of Person(s) Filing Proxy Statement if other than Registrant)** 

Payment of Filing Fee (Check all boxes that apply):

☒ No fee required

☐ Fee paid previously with preliminary materials

☐ Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11

------

![LOGO](g88080dsp002.jpg)

Your Vote Counts! <br>TRANSMEDICS GROUP, INC. <br>2026 Annual Meeting Vote by May 19, 2026 <br>11:59 PM ET <br>TRANSMEDICS GROUP, INC.200 MINUTEMAN ROAD, SUITE 302ANDOVER, MA 01810 <br>V94188-P45932 <br>You invested in TRANSMEDICS GROUP, INC. and it's time to vote! <br>You have the right to vote on proposals being presented at the Annual Meeting. This is an important notice regarding the availability of proxy materials for the shareholder meeting to be held on May 20, 2026. <br>Get informed before you vote <br>View the Notice and Proxy Statement and Form 10-K online OR you can receive a free paper or email copy of the material(s) by requesting prior to May 6, 2026. If you would like to request a copy of the material(s) for this and/or future shareholder meetings, you may (1) visit www.ProxyVote.com, (2) call 1-800-579-1639 or (3) send an email to sendmaterial@proxyvote.com. If sending an email, please include your control number (indicated below) in the subject line. Unless requested, you will not otherwise receive a paper or email copy.For complete information and to vote, visit www.ProxyVote.comControl # <br>For complete information and to vote, visit www.ProxyVote.com <br>Control # <br>Smartphone users <br>Point your camera here and vote without entering a control number <br>Vote Virtually at the Meeting\* <br>May 20, 2026 <br>8:00 A.M. Eastern Time <br>Virtually at:www.virtualshareholdermeeting.com/TMDX2026 <br>\*Please check the meeting materials for any special requirements for meeting attendance.

------

![LOGO](g88080dsp003.jpg)

Vote at www.ProxyVote.com <br>THIS IS NOT A VOTABLE BALLOT <br>This is an overview of the proposals being presented at the upcoming shareholder meeting. Please follow the instructions on the reverse side to vote these important matters. <br>Board Recommends <br>Voting Items <br>1. Election of Directors <br>Nominees: <br>1a. Waleed H. Hassanein, M.D. For <br>1b. James R. Tobin For <br>1c. Edward M. Basile For <br>1d. Thomas J. Gunderson For <br>1e. Edwin M. Kania, Jr. For <br>1f. Stephanie Lovell For <br>1g. Merilee Raines For <br>1h. David Weill, M.D. For <br>2. To approve, on a non-binding advisory basis, the compensation paid to TransMedics' named executive officers. For <br>3. To approve an amendment to the TransMedics Group, Inc. Amended and Restated 2019 Stock Incentive Plan to increase the maximum aggregate number of shares of common stock that may be issued pursuant to awards granted under the TransMedics Group, Inc. Amended and Restated 2019 Stock Incentive Plan by 2,750,000 shares and make certain other changes as set forth in the proxy statement. For <br>4. To ratify the appointment of PricewaterhouseCoopers LLP as TransMedics Group, Inc.'s independent registered public accounting firm for the fiscal year ending December 31, 2026. For <br>NOTE: Such other business as may properly come before the meeting or any adjournment thereof. <br>Prefer to receive an email instead? White voting on www.ProxyVote.com, be sure to click "Delivery Setting". <br>V94189-P45932